Acadia: 4Q Earnings Snapshot

February 26, 2020 GMT

SAN DIEGO (AP) _ Acadia Pharmaceuticals Inc. (ACAD) on Wednesday reported a loss of $53 million in its fourth quarter.

The San Diego-based company said it had a loss of 34 cents per share.

The results surpassed Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 37 cents per share.

The drugmaker posted revenue of $98.3 million in the period, also topping Street forecasts. Six analysts surveyed by Zacks expected $95.9 million.

For the year, the company reported that its loss narrowed to $235.3 million, or $1.60 per share. Revenue was reported as $339.1 million.

Acadia shares have fallen 6% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $40.22, a climb of 71% in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ACAD at https://www.zacks.com/ap/ACAD